All Product Search


Searching all of our products for "Cardiovascular" we found the following results:





97 Market Reports Found


Search results:
  1. European Markets for Percutaneous Transluminal Corronary Angioplasty and Coronary Stenting Products
    Coronary heart disease (CHD) is responsible for more than 1.9 million deaths in Europe each year, accounting for 21.0% o ...[more]
  2. U.S. Markets for Cardiac Rhythm Management Products
    Cardiac rhythm disorders-also called arrhythmias or dysrhythmias-encompass a variety of relatively common chronic condit ...[more]
  3. India Surgical Procedure Volumes
    Overview available upon request to sales@LifeScienceIntelligence.co ...[more]
  4. Japan Surgical Procedure Volumes
    It is estimated that four million surgeries were performed in Japan in 2010. With one of the lowest per capita healthca ...[more]
  5. China Surgical Procedure Volumes
    It is estimated that 30 million surgical procedures will be performed in China in 2010. As the country performing the l ...[more]
  6. U.S. Markets for Cardiac and Vascular Tissue Engineering Products
    Due to the large number of potential patients targeted by tissue engineering and cell transplantation technologies/produ ...[more]
  7. Opportunities in Global Medical Devices & Diagnostics
    The global medical device and diagnostics (MD&D) industry experienced negligible growth in 2009 as the worldwide econom ...[more]
  8. U.S. Opportunities in Acute Cardiac Assist Technologies
    Acute cardiac assist technologies, encompassing intra-aortic balloon pumps (IABPs), percutaneous ventricular assist devi ...[more]
  9. China Market for Interventional Cardiology Products
    Cardiovascular disease is the leading cause of death in China and has become a major epidemic, killing an estimated 2.6 ...[more]
  10. The Worldwide Clinical Diagnostics Market
    Major Topics •    Trends in the global clinical diagnostics market and 2009-2015 market ...[more]
  11. European Markets for Image-Guided Surgery Products
    Image-guided surgery (IGS) refers to any surgical procedure involving the intraoperative use of a representation of pati ...[more]
  12. U.S. Markets for Interventional Cardiology Products
    Every 25 seconds someone in the U.S. will suffer a coronary event, and every 60 seconds someone will die from such an ev ...[more]
  13. Emerging Medical Technologies Report
    This 1,300+ page report includes detailed 2-3 page executive summaries on 577 emerging medical technology companies who ...[more]
  14. U.S. Organ and Tissue Transplantation Procedure Volumes
    The number of surgical procedures performed in the United States (U.S.) is increasing; however, the share of inpatient h ...[more]
  15. U.S. Cardiovascular Surgical Procedure Volumes
    The number of surgical procedures performed in the United States (U.S.) is increasing; however, the share of inpatient h ...[more]
  16. Opportunities in Cardiovascular Devices: Global Market Overview
    The global medical device and diagnostics (MD&D) industry generated nearly $286 billion in revenues in 2007, with contin ...[more]
  17. The Chinese Hospital Drug Utilization Volume (2nd Edition 2009)
    The total Chinese pharmaceutical market reached RMB 828.4 billion (US$ 120.8 billion, at an exchange rate of US $1 = RMB ...[more]
  18. U.S. Markets for Computer-Aided Diagnostic Imaging Products
    In 2008, approximately 370 million noninvasive and minimally invasive imaging procedures were performed in the United St ...[more]
  19. European Markets for Cardiopulmonary Support Products
    This dynamic, new report from Medtech Insight includes analyses of products, markets, competitors, and opportunities in ...[more]
  20. European Markets for Transfusion Management Products
    In Europe, approximately 2 million patients lose a sufficient amount of blood annually to require the transfusion of at ...[more]
  21. Worldwide Markets and Emerging Technologies for Point-of-Care Testing
    Major Topics Include: • Trends in the global clinical diagnostics market and 2008-2014 market analysis ...[more]
  22. United Kingdom, Surgical Procedure Volumes
    In 2008, the population of the United Kingdom (U.K.) reached approximately 60.9 million, with the number of people age 6 ...[more]
  23. Spain, Surgical Procedure Volumes
    In 2008, the population of Spain reached approximately 40.5 million, with the number of people age 65 and older comprisi ...[more]
  24. Italy, Surgical Procedure Volumes
    In 2008, the population of Italy reached approximately 58.1 million, with the number of people age 65 and older comprisi ...[more]
  25. Germany, Surgical Procedure Volumes
    The number of people age 65 and older comprises 20% of Germany's population of more than 82 million; by the year 2018, i ...[more]
  26. France, Surgical Procedure Volumes
    France, with a population of more than 64 million, has one of the highest levels of healthcare spending in Europe. Fran ...[more]
  27. European Markets for Temperature Management Products for Hospitals
    Temperature management is a life-saving tool in hospital critical care units. Hypothermia occurs in 21% to 66% of all t ...[more]
  28. U.S. Opportunities in Surgical Heart Valve Technologies
    Transcatheter heart valve technologies are positioned to become the next disruptive influence in cardiovascular medicine ...[more]
  29. U.S. Opportunities in Transcatheter Heart Valve Technologies
    Transcatheter heart valve technologies are positioned to become the next disruptive influence in cardiovascular medicine ...[more]
  30. India Market for Interventional Cardiology Products
    The market for interventional cardiology products in India is growing in line with a dramatic rise in cardiovascular dis ...[more]
  31. European Markets for Critical Care Blood Gas Monitoring Products
    Blood gas measurements are a valuable tool used by clinicians to monitor patients with respiratory distress symptoms as ...[more]
  32. European Markets for ECG and Cardiovascular Disease-Related In Vitro Diagnostic Near-Patient Testing Products
    In Europe, more than 4.3 million people die every year from cardiovascular diseases/disorders such as stroke and coronar ...[more]
  33. China Hypertension Drug Market
    Epidemiology data indicate that there are about 200 million hypertension patients in China. Every year there are 2 milli ...[more]
  34. Worldwide Markets and Emerging Technologies for Tissue Engineering and Regenerative Medicine
    The tissue engineering and regenerative medicine market first emerged in the mid-1990's with the introduction of product ...[more]
  35. U.S. Long-Term Acute Care Markets
    Faced with escalating costs, acute hospitals require alternative care locations to accommodate the needs of extended-sta ...[more]
  36. U.S. Markets for Current and Emerging Wound Closure Technologies
    In 2008, more than 100 million wounds were treated in U.S. hospitals; these included surgical wounds; traumatic wounds; ...[more]
  37. European Markets for Cardiovascular Disease Diagnostic Imaging Products
    In Europe, more than 4.3 million people die every year from cardiovascular diseases/disorders such as stroke and coronar ...[more]
  38. U.S. Surgical Procedure Volumes
    The number of surgical procedures performed in the United States (U.S.) is increasing; however, the share of inpatient h ...[more]
  39. Opportunities in Global Medical Devices and Diagnostics
    The global medical device and diagnostics (MD&D) industry generated nearly $286 billion in revenues in 2007, with contin ...[more]
  40. European Markets for Critical Care Patient Monitoring Products
    In 2007, sales of critical care patient monitoring products in the European countries of France, Germany, Italy, Spain, ...[more]
  41. Current and Emerging U.S. Markets for Myocardial Revascularization, Repair, and Regeneration Products and Technologies
    Heart disease is the leading cause of death in the U.S., killing one person nearly every minute. Coronary heart disease- ...[more]
  42. U.S. Disease Incidence and Prevalence
    Major diseases/disorders in the United States (U.S.)--from cancer and cardiovascular diseases/disorders to acquired immu ...[more]
  43. Opportunities in Chinese Cardiovascular Device Markets
    CHINESE MARKET FOR CARDIOVASCULAR DEVICES FORECAST TO GROW 18% ANNUALLY THROUGH 2013, DRIVEN BY EXPANDED SERVICES AND PR ...[more]
  44. European Disease Incidence and Prevalence
    Major diseases in Europe (from cancer and cardiovascular disease to neurologic and psychiatric disorders) take their tol ...[more]
  45. Global Vascular Closure Device Markets: U.S., Europe, Rest of World
    As analyzed in this report by Life Science Intelligence, the global market for vascular closure devices will reach nearl ...[more]
  46. U.S. Markets for Directed Energy-Based Surgical Systems
    Tissue-altering directed energy-based surgical systems utilizing cryogenic, laser, microwave, radiofrequency, or ultraso ...[more]
  47. European Markets for Heart Valve Repair and Replacement Products
    As the sizable European population both grows and ages, the number of people in the region living with congenital or acq ...[more]
  48. U.S. Surgical Procedure Volumes
    The number of surgical procedures performed in the United States (U.S.) is increasing; however, the share of inpatient h ...[more]
  49. U.S. Markets for Image-Guided Surgery Products
    Over the past decade, image-guided surgery has become a recognized standard of care in the management of a number of cra ...[more]
  50. Tissue Engineering and Cell Transplantation: Technologies, Opportunities, and Evolving Markets in the U.S.
    Due to the large number of potential patients targeted by tissue engineering and organ regeneration products, and the ma ...[more]
  51. U.S. Markets for Percutaneous Transluminal Coronary Angioplasty and Coronary Stenting Products
    Percutaneous transluminal coronary angioplasty (PTCA) and coronary stenting represent the device-based, non-surgical tre ...[more]
  52. Current and Emerging Technologies for the Management of Heart Failure in the U.S.
    More than 5 million people in the U.S. are now being managed for heart failure, with 550,000 new cases occurring annuall ...[more]
  53. U.S. Opportunities in Atrial Fibrillation Technologies
    The medical industry has clearly realized that atrial fibrillation (AF) represents a major market opportunity, as the af ...[more]
  54. Opportunities in Global Medical Devices and Diagnostics
    The global medical device and diagnostics (MD&D) industry generated nearly $220 billion in revenues in 2005, of which ne ...[more]
  55. U.S. Opportunities in Surgical Coronary Revascularization
    The U.S. launch of drug-eluting stents (DES) in early 2003 produced an immediate and fairly dramatic decline in coronary ...[more]
  56. European Surgical Procedure Volumes
    In previous years, conventional, open surgical procedures in the European Union (EU) countries of France, Germany, Ital ...[more]
  57. European Markets for Minimally Invasive Cardiac Surgery and Intracoronary Diagnostic Devices
    Cardiovascular disease (CVD) is the leading cause of death in Europe, accounting for more than 4.35 million deaths annu ...[more]
  58. European Markets for Prosthetic Vascular Grafts
    In Europe, more than 4.35 million deaths are attributable to cardiovascular disease (CVD) each year, while more than 48 ...[more]
  59. Worldwide Markets and Emerging Technologies for Point-of-Care Testing
    Major Topics • Trends in the global clinical diagnostics market and market analys ...[more]
  60. Opportunities in Heart Valve Disease Management: Europe, Japan and Rest of World
    Although Europe and Japan have large, aging populations subject to degenerative heart conditions, and the ...[more]
  61. U.S. Opportunities in Heart Valve Disease Management
    The United States (U.S.) heart valve market is entering a period of transformation. The agi ...[more]
  62. U.S. Disease Incidence and Prevalence
    As the population in the United States (U.S.) ages and life spans increase, the incidence and prevalence of major diseas ...[more]
  63. U.S. Markets for Computer-Aided Diagnostic Imaging Products
    In 2004, the worldwide computer-aided diagnostic (CAD) imaging products market was valued at $15 billion; in the same ye ...[more]
  64. U.S. Markets for Diagnostic Imaging Systems
    Diagnostic imaging systems, which enable clinicians to visualize the anatomic structure and evaluate the functional perf ...[more]
  65. U.S. Markets for Directed Energy-Based Surgical Systems
    Directed energy-based surgical therapy employs the controlled deposition of energy into targeted tissues to achieve a de ...[more]
  66. European Markets for Percutaneous Transluminal Coronary Angioplasty and Coronary Stenting Products
    Coronary artery disease is the leading cause of death in Europe. The morbidity/mortality rates associated with the dise ...[more]
  67. U.S. Markets for Arrhythmia Management Products
    Cardiac arrhythmias affect more than 5 million people nationwide, and result in more than 1.2 million hospitalizations a ...[more]
  68. U.S. Markets for Interventional Cardiology Products
    More adults in the U.S. die from cardiovascular diseases/disorders than from any other cause. Nationwide, approximately ...[more]
  69. U.S. Opportunities in Drug Delivery Technologies
    The U.S. drug delivery market is entering a watershed period. Traditional infusion products ...[more]
  70. U.S. Opportunities in Heart Failure Technologies
    Heart failure is a complex, clinical syndrome characterized by multiple causes, symptoms and ...[more]
  71. U.S. Markets for Critical Care Patient Monitoring Products
    Critical care units are the most expensive sites in the U.S. healthcare system, accounting for 30% to 40% of an acute ca ...[more]
  72. U.S. Markets for Critical Care Patient Management Products
    Critical care units are the most expensive sites in the U.S. healthcare system, accounting for 30% to 40% of an acute ca ...[more]
  73. Emerging U.S. Markets for Myocardial Revascularization, Repair, and Regeneration Products and Technologies
    In the United States (U.S.), cardiovascular disease afflicts more than a quarter of the population, causes more than 5 m ...[more]
  74. U.S. Markets for Cardiovascular Disease Diagnostic Products
    More adults in the U.S. die from cardiovascular diseases/disorders than from any other cause. Nationwide, approximately ...[more]
  75. U.S. Markets for Point-of-Care Diagnostics
    Point-of-care diagnostic technology includes portable, instrument-based diagnostic devices used in near-patient hospital ...[more]
  76. Opportunities in U.S. Peripheral Vascular Stent Markets
    The overwhelming success of stenting in the coronary arteries has created strong interest in ...[more]
  77. Current and Emerging Wound Closure Products and Techniques in Europe and the U.S.
    In an effort to address the major barriers to the adoption of minimally invasive techniques in wound closure, manufactur ...[more]
  78. The Worldwide Market for Diagnostic Imaging Equipment
    Diagnostic imaging tools enabling clinicians to visualize the anatomic structure and evaluate the functional performance ...[more]
  79. U.S. Markets for Percutaneous Transluminal Coronary Angioplasty and Coronary Stent Products
    Despite major technology-driven advances in the management of coronary artery disease, more than 450,000 people die from ...[more]
  80. U.S. Opportunities in the Management of Atrial Fibrillation
    Atrial fibrillation (AF) affects an estimated 2.3 million Americans at present, of which nearly 70% are 70 years of age ...[more]
  81. High Growth U.S. Adjunctive Coronary Transcatheter Markets
    The introduction of interventional coronary techniques in the late 1970's has provided physicians with a valuable and cl ...[more]
  82. U.S. Opportunities in Heart Valve Disease Management
    Hundreds of thousands of patients in the U.S., including a large share with congestive heart failure, coul ...[more]
  83. U.S. Opportunities in Interventional Coronary Revascularization
    Coronary stents represent one of the most successful product launches in the history of the medical products i ...[more]
  84. Emerging Medical Marketplace Overview Latin America: Peru
    In 1999, Peru's population totaled approximately 25,348,046. In the same year, the country spent approximately 4.7% ($2 ...[more]
  85. Emerging Medical Marketplace Overview Latin America: Mexico
    ...[more]
  86. U.S. Markets for Current and Emerging Wound Closure Technologies, 2001-2011
    One of the major barriers to the adoption of minimally invasive techniques in wound closure has been the difficulty asso ...[more]
  87. New Strategies in Cardiovascular Disease Management Programs
    According to the Centers for Disease Control and Prevention, more than 90 million Americans live with some form of chron ...[more]
  88. European Markets for Arrhythmia Management Products
    Heart disease is the world's leading cause of death for both men and women among all racial and ethnic groups. Each yea ...[more]
  89. European Markets for Transcatheter Cardiovascular Therapy
    Despite scientific advancement in the understanding and management of cardiovascular disease, it remains the leading hea ...[more]
  90. Emerging Medical Marketplace Overview Latin America: Colombia
    ...[more]
  91. Emerging Medical Marketplace Overview Latin America: Chile
    ...[more]
  92. Emerging Medical Marketplace Overview Latin America: Brazil
    ...[more]
  93. Emerging Medical Marketplace Overview Latin America: Argentina
    ...[more]
  94. European Markets for Cardiovascular Diagnostics, 2000-2005
    Cardiovascular diseases impose a heavy socioeconomic burden on European healthcare systems. In the five largest Europea ...[more]
  95. Strategic Growth Opportunities in Cardiovascular Interventional Product Markets, 2000-2010
    This report is a detailed market and technology assessment and forecast of the current and emerging products in interven ...[more]
  96. U.S. Cardiac Catheterization Laboratories: End-User Product and Procedure Utilization Assessment
    The cardiac catheterization laboratory, or cath lab, is one of the busiest and most device-intensive areas of the hospit ...[more]
  97. U.S. Markets for Cardiovascular and Cardiothoracic Surgery Devices
    The future holds strong growth for the overall cardiovascular surgery products market, however, as new technologies evol ...[more]
 


277 EMT Companies Found


Search results:
  1. EMT Company 1197
    Patient monitoring system providing real-time continuous information via four physiological parameters - sensed at the t ...[more]
  2. EMT Company 937
    Advanced blood purification to reduce cytokine storm and inflammation that leads to multi-organ failure in sepsis and ot ...[more]
  3. EMT Company 1200
    Reagents for use in non-invasive MRI, PET, and optical imaging ...[more]
  4. EMT Company 667
    Non-invasive, fully automated system for the accurate assessment of : cardiovascular/diabetic autonomic neuropathy, effe ...[more]
  5. EMT Company 399
    First viable intracellular genetic protein therapy for the treatment of Chronic Heart Failure (\"CHF\") ...[more]
  6. EMT Company 1202
    Lightweight and portable system with unsurpassed fluid balance accuracy for blood purification and fluid management ...[more]
  7. EMT Company 1203
    Forward-looking intravascular ultrasound (FLIVUS) catheters that can determine correct stent size and placement through ...[more]
  8. EMT Company 869
    Allogeneic cell therapy derived from the human placenta to mimic the natural environment of bone marrow ...[more]
  9. EMT Company 868
    Aortic embolic protection device for acute and long-term use ...[more]
  10. EMT Company 1206
    Effective, reliable use of autologous adult stem cells (ASCs) to enhance fusion in spine and orthopedic surgery ...[more]
  11. EMT Company 564
    Cardiac mapping system that is non-invasive, maps the entire heart in one beat, and provides catheter localization ...[more]
  12. EMT Company 1185
    Highly accurate, minimally invasive, automatic, and continuous system to measure and monitor cardiac output, total circu ...[more]
  13. EMT Company 1186
    Needle technology that reveals visible blood flow at the instant of vein penetration without activation or additional in ...[more]
  14. EMT Company 722
    Rapid, point-of-care diagnostic tests for periodontitis/group A strep/systemic fungal infections, capable of detecting v ...[more]
  15. EMT Company 946
    1-Biopsy needles with enhanced ultrasound visualization, 2-Microencapsulated tissue markers, 3-Devices for the local, ac ...[more]
  16. EMT Company 563
    Repair and regeneration technology platforms designed to mend and regrow hard tissue (such as bone) and soft tissue (suc ...[more]
  17. EMT Company 596
    Catheter-based systems that will provide very rapid/selective hypothermia to various body organs and locations ...[more]
  18. EMT Company 1193
    Bioceramics for the treatment of post-myocardial infarction (MI), mitral valve regurgitation, applications to coronary a ...[more]
  19. EMT Company 185
    Neuro-monitoring systems for brain protection and stroke acute care in stroke units, cardiovascular ORs, during stenting ...[more]
  20. EMT Company 161
    Transcatheter mitral valve repair - will move mitral valve annuloplasty from a major open heart surgical procedure to a ...[more]
  21. EMT Company 1164
    A vascular robotic system designed to place coronary guidewires, stents, and balloon catheters during percutaneous coron ...[more]
  22. EMT Company 1155
    Quantitative and qualitative cardiac assays to assist in the diagnosis of cardiovascular diseases at the point of care ...[more]
  23. EMT Company 1161
    Controlled Deployment Technology (CDT), which uses a low-profile access sheath that may be increased to provide a wider ...[more]
  24. EMT Company 1160
    A portable device that provides therapeutic hypothermia in emergency care settings ...[more]
  25. EMT Company 1116
    Software systems for cardiology ...[more]
  26. EMT Company 1130
    Liposome-encased nanoparticles for computed tomography (CT) contrast imaging ...[more]
  27. EMT Company 1123
    A drug-eluting stent coated with bioabsorbable polymers ...[more]
  28. EMT Company 1132
    Portable hyperthermic perfusion system for raising the core temperature of the thoracic or peritoneal cavity ...[more]
  29. EMT Company 1170
    Implantable device to treat patients with left ventricular dilation following a Myocardial Infarction (MI) heart attack ...[more]
  30. EMT Company 1171
    Modern, sophisticated system to ensure a proper blood match is obtained and the patient gets the correct cord blood unit ...[more]
  31. EMT Company 668
    Nanotechnology surface treatments for combination medical devices that address nosocomial (in-hospital) infections and t ...[more]
  32. EMT Company 700
    Pressure-controlled Intermittent Coronary Sinus Occlusion (PICSO) device for acute coronary syndrome (ACS) and heart fai ...[more]
  33. EMT Company 1174
    Biomimetic prosthetic vascular grafts that are transformed in the body into bioartificial arteries which resemble \"heal ...[more]
  34. EMT Company 1175
    1-Real-time device navigation and positioning system for cardiovascular interventions and 2-Real-time angiography-based ...[more]
  35. EMT Company 1178
    Next-generation robotic surgery system that is: complete, sensitive, flexible, very light, compact, and cost-effective ...[more]
  36. EMT Company 1179
    Tissue-engineered, autologous heart valves for the replacement of malformed or malfunctioning heart valves ...[more]
  37. EMT Company 833
    Technology that uses the patient\'s own blood to make either: 1-A surgical sealant to prevent/stop bleedings or 2-A gel ...[more]
  38. EMT Company 799
    Compact, remote, wireless, real-time device for biomedical monitoring such as cardiac, neurological, sleep disorder, obs ...[more]
  39. EMT Company 1098
    Selective cytopheresis-based, modulating system to address inflammation-based diseases and conditions ...[more]
  40. EMT Company 1052
    Device that creates a reliable anastomosis to any graft site, for use in CABG and vascular surgeries ...[more]
  41. EMT Company 572
    Technology that provides the precision of a scalpel and the bleeding control of traditional electrosurgery, without exte ...[more]
  42. EMT Company 1112
    Highly differentiated aorto-ostial stent and delivery platform for both peripheral and coronary applications ...[more]
  43. EMT Company 1086
    Interventional cardiology devices for chronic total occlusions ...[more]
  44. EMT Company 1089
    Wireless electrocardiography ...[more]
  45. EMT Company 579
    Implantable patient alerting system for the detection and prevention of heart attacks ...[more]
  46. EMT Company 1063
    Rapid endovascular vessel occlusion and blood flow interruption ...[more]
  47. EMT Company 1064
    Suite of diagnostic imaging products using near-field and forced-resonance principles targeting several specialties incl ...[more]
  48. EMT Company 801
    Non-invasive devices to identify patients with coronary artery disease (CAD) and other life-threatening cardiovascular c ...[more]
  49. EMT Company 644
    Aortic valve bypass graft system for use as a minimally invasive, beating heart alternative to traditional aortic valve ...[more]
  50. EMT Company 1065
    Portable diagnostic device used to determine the presence and level of Myocardial Ischemia (MI) ...[more]
  51. EMT Company 1066
    Point-of-care automated optical diagnostic device for platelet quality testing ...[more]
  52. EMT Company 1071
    RFID technology and software systems for medical device manufacturers, distributors, and hospitals ...[more]
  53. EMT Company 1073
    Therapeutic ultrasound to treat hypertension ...[more]
  54. EMT Company 522
    Device to percutaneously repair the mitral valve ...[more]
  55. EMT Company 1027
    1-System for use in spinal surgical procedures such as vertebroplasty, 2-System to provide immediate vascular access thr ...[more]
  56. EMT Company 1010
    Hydrogel materials that can be fabricated into devices, nanogels, and polymer solutions with applications in ophthalmolo ...[more]
  57. EMT Company 1009
    Advanced polymer-based biomaterials for applications in cardiology, dentistry, orthopedics, surgery, and urology ...[more]
  58. EMT Company 1003
    Elastic, self-expanding devices to specifically improve left ventricle relaxation and diastolic function ...[more]
  59. EMT Company 1002
    Point-of-care handheld immunoassay system providing high-performance quantitative laboratory blood test results in an in ...[more]
  60. EMT Company 1001
    Routine serum DNA blood tests for early cancer diagnosis and management ...[more]
  61. EMT Company 999
    Drug-eluting balloons that allow for controlled release of different and even multiple substances, for the treatment of ...[more]
  62. EMT Company 8
    Cell-based therapy products for the treatment of heart failure secondary to myocardial infarction ...[more]
  63. EMT Company 192
    Coronary guidewire, to provide real-time ultrasonic measurement of coronary arteries to determine stent size and apposit ...[more]
  64. EMT Company 907
    1-Bioactive/conductive polymer materials and coatings for implantable biomedical devices and 2-Next-generation all-polym ...[more]
  65. EMT Company 278
    Biocompatible polymer implant to prevent or reverse the progression of chronic heart failure and mitral valve regurgitat ...[more]
  66. EMT Company 14
    Non-invasive modality for the treatment of insulin resistance/diabetic neuropathy ...[more]
  67. EMT Company 1056
    Miniature/high-resolution/low-cost CMOS (complimentary metal-oxide semiconductor) image sensors for use in disposable en ...[more]
  68. EMT Company 595
    Cardiac assist device for patients in moderate/severe long-term heart failure ...[more]
  69. EMT Company 460
    Biomaterials-based medical devices focusing on cardiovascular, metabolic, inflammatory, and fibrotic diseases ...[more]
  70. EMT Company 285
    A drug delivery platform that approaches the endovascular bifurcation challenge from a completely different angle ...[more]
  71. EMT Company 239
    Naturally occurring neuropeptide to treat ischemia associated with myocardial infarction, heart failure, and angina ...[more]
  72. EMT Company 358
    Ceramic components for spine, orthopaedic, and other implant needs ...[more]
  73. EMT Company 978
    Next-generation endovascular devices that incorporate advanced fiber optics technology into currently used products/proc ...[more]
  74. EMT Company 979
    In-line, battery-powered, disposable, lightweight, and completely portable blood and IV fluid warming device, capable of ...[more]
  75. EMT Company 980
    Next-generation stent platform with: significantly thin walls for reduced restenosis, ease-of-use, superior deliverabil ...[more]
  76. EMT Company 981
    Handheld, non-invasive, real-time Central Venous Pressure (CVP) monitor for cardiology and nephrology diagnostic applica ...[more]
  77. EMT Company 462
    Dynamic "shape memory" platform to optimize mitral/tricuspid valve repair ...[more]
  78. EMT Company 982
    Ventricular Assist Device (VAD) that can be inserted above the diaphragm ...[more]
  79. EMT Company 985
    System designed to prevent contrast-induced nephropathy (CIN) ...[more]
  80. EMT Company 989
    Total Artificial Heart (TAH) to replace both ventricles of a failed heart, thus, restoring the circulatory system to nor ...[more]
  81. EMT Company 990
    Next-generation remote patient monitoring (RPM) to continuously monitor vital life-sign functions such as: heart rate, ...[more]
  82. EMT Company 318
    Biocellulose technology that eliminates the risks/complications/limitations inherent in animal, human, and synthetic bio ...[more]
  83. EMT Company 366
    High-intensity focused ultrasound in a catheter to treat atrial fibrillation ...[more]
  84. EMT Company 517
    Percutaneous mitral valve replacement (PMVR) for Mitral Regurgitation (MR) ...[more]
  85. EMT Company 959
    1-Multi-generational devices using hybrid technologies for Natural Orifice Translumenal Endoscopic Surgery (NOTES) proce ...[more]
  86. EMT Company 637
    Guidewire system intended to safely/quickly cross occluded peripheral and coronary vessels ...[more]
  87. EMT Company 617
    Diagnostic and therapeutic catheter-based devices for prevention/treatment of heart attacks caused by soft plaque ...[more]
  88. EMT Company 930
    Next-generation vessel closure ...[more]
  89. EMT Company 110
    Percutaneous noninvasive heart valve replacement ...[more]
  90. EMT Company 513
    Bioresorbable peripheral/coronary polymer stents that promote the natural remodeling of an injured artery after angiopla ...[more]
  91. EMT Company 142
    1-Bio-therapeutic designed from autologous stem cells and committed to a cardiac lineage before implantation, 2-Correspo ...[more]
  92. EMT Company 143
    Noninvasive device using muscular counter pulsation (MCP) technology for the treatment of chronic heart failure (CHF) ...[more]
  93. EMT Company 964
    Precision stapling devices enabling minimally invasive vascular connections, especially for Coronary Artery Bypass Graft ...[more]
  94. EMT Company 935
    Injectable biopolymer for the direct treatment of acute myocardial infarction (AMI) ...[more]
  95. EMT Company 940
    1-System for remote home patient monitoring of glucose, blood pressure, and thermal weight, 2-Glucose meter cell phone ...[more]
  96. EMT Company 122
    Non-invasive medical radar imaging for cardiopulmonary ambulatory monitoring and diagnosis ...[more]
  97. EMT Company 948
    Surgical instrument designed to solve recurrent problems in managing sutures, tissue reattachment, and visualization dur ...[more]
  98. EMT Company 416
    Minimally invasive catheter-based ablation technologies to treat atrial fibrillation and other cardiac arrhythmias ...[more]
  99. EMT Company 914
    "Smart" cells than can determine the type of disease/injury present in the body and repair/regenerate tissue accordingly ...[more]
  100. EMT Company 916
    Non-invasive vascular disease detection that combines the advantages of MRI with the temporal resolution and ease-of-use ...[more]
  101. EMT Company 926
    Lab-free salt intake monitor for hypertension/congestive heart failure (CHF) patients ...[more]
  102. EMT Company 872
    Neuromodulation for hypertension/heart failure ...[more]
  103. EMT Company 874
    Tests for the diagnosis/prognosis of cardiovascular disease ...[more]
  104. EMT Company 875
    Portable/rapid cooling technologies via the nasal cavity to improve patient outcomes after cardiac arrest, stroke, or tr ...[more]
  105. EMT Company 879
    Artificial heart technologies ...[more]
  106. EMT Company 881
    Compliant balloon platform technology for use in neuroradiology, cardiovascular, and peripheral vascular applications ...[more]
  107. EMT Company 882
    Inferior vena cava (IVC) filter that includes: 1-automatic self-centering, 2-bi-directional deployment and retrieval, 3 ...[more]
  108. EMT Company 888
    Variety of diagnostic tests for infectious diseases, cardiology, hepatology, and various cancers ...[more]
  109. EMT Company 889
    Non-polymeric drug-eluting stent (DES) ...[more]
  110. EMT Company 895
    Nanomaterials for angiogenesis/anti-angiogenesis/diagnostic applications ...[more]
  111. EMT Company 899
    Heart pump technologies ...[more]
  112. EMT Company 155
    Minimally-invasive cardiac implantable devices for treating mitral valve regurgitation without atriotomy or cardiopulmon ...[more]
  113. EMT Company 838
    Heart valve implant ...[more]
  114. EMT Company 839
    Fully implantable device for the treatment of central sleep apnea in heart failure patients ...[more]
  115. EMT Company 840
    Permanently implantable/wireless/miniature sensors to transmit cardiac output, blood pressure, and heart rate data ...[more]
  116. EMT Company 841
    Artificial heart made of biosynthetic tissues, with two-pumps ...[more]
  117. EMT Company 844
    Biomaterial with exceptional hardness/low friction/bio-inertness that also prevents the leaching of metallic ions into t ...[more]
  118. EMT Company 845
    Products for coronary bypass, valve repair and replacement, cardiac ablation, and heart failure surgery ...[more]
  119. EMT Company 847
    Catheter insertion systems, designed for extended IV dwell time, to eliminate the risk of related bloodstream infections ...[more]
  120. EMT Company 861
    Next-generation nanostructured capacitors for: 1-implantable cardiac defibrillators (ICD) and 2-microsteerable cardiac a ...[more]
  121. EMT Company 261
    Naturally-derived/non-crosslinked/collagen-based extracellular matrix to repair/remodel damaged tissues ...[more]
  122. EMT Company 807
    Monitoring products/clinical services for advanced ambulatory cardiac monitoring ...[more]
  123. EMT Company 808
    Catheter ablation for the treatment of cardiac arrhythmias ...[more]
  124. EMT Company 811
    Fluorescent markers/optical sensors that provide an accurate and rapid determination of kidney function ...[more]
  125. EMT Company 293
    1-Instant-on/instant-off proximal occlusion funnel catheter, 2-Scoring balloon with drug delivery capability ...[more]
  126. EMT Company 492
    Stent that provides protection from embolic showers during/post-procedure ...[more]
  127. EMT Company 570
    System that enables consistent tissue contact/complete lesions during cardiac surgery for the treatment of arrhythmias ...[more]
  128. EMT Company 821
    Wearable health monitoring system for potential diabetes, heart disease, and sleep apnea applications ...[more]
  129. EMT Company 822
    Pocket-sized, affordable, and easy-to-use resuscitation devices that can be effectively deployed by both trained profess ...[more]
  130. EMT Company 823
    1-Pacing/sensor-enabled device for Cardiac Resynchronization Therapy (CRT), 2-Real-time modality to quantify cardiac per ...[more]
  131. EMT Company 776
    Neurostimulator for cardiac contractility ...[more]
  132. EMT Company 787
    Drug-coated balloon angioplasty technology ...[more]
  133. EMT Company 789
    1-Prohealing coronary stent as an alternative to drug-eluting stents (DES), 2-Balloon -expandable/crush-resistant nitino ...[more]
  134. EMT Company 793
    Next- generation/predictive blood tests to help warn of potential future health problems ...[more]
  135. EMT Company 798
    Permanent implant to address mitral regurgitation directly ...[more]
  136. EMT Company 741
    1-Next-generation, natural fibrin sealant, 2-Human thrombin ...[more]
  137. EMT Company 743
    Custom miniaturized mechanical components/devices for a broad range of medical device applications ...[more]
  138. EMT Company 769
    Tests to "predict" chronic diseases/conditions, such as diabetes/osteoporotic bone fracture/a major cardiac event ...[more]
  139. EMT Company 748
    In vivo transdifferentiation to regenerate ischemic/diseased organs ...[more]
  140. EMT Company 770
    Technology to treat atrial fibrillation that allows doctors to perform radiofrequency ablation under direct visualizatio ...[more]
  141. EMT Company 716
    Molecular imaging of apoptosis (programmed cell death) for disease detection/monitoring ...[more]
  142. EMT Company 726
    Percutaneously deliverable endograft to treat Abdominal Aortic Aneurysms (AAA) and Thoracic Aortic Aneurysms (TAA) ...[more]
  143. EMT Company 125
    Interventional catheter-based system precisely measures stent and arterial size and cardiovascular repair tissue patch p ...[more]
  144. EMT Company 690
    Leadless/subcutaneously implantable cardiac defibrillator (ICD) ...[more]
  145. EMT Company 691
    Polymer technologies for cardiac/cranio-maxillofacial/orthopedic surgery applications ...[more]
  146. EMT Company 695
    Leadless/implantable pacing device for left ventricular stimulation/the treatment of heart failure ...[more]
  147. EMT Company 701
    Next-generation coatings/advanced drug-delivery systems for cardiovascular stents and other implantable medical devices ...[more]
  148. EMT Company 711
    Devices for the destruction of pathogens responsible for: heart/blood/respiratory/gastrointestinal/periodontal/otologica ...[more]
  149. EMT Company 714
    Transitional in vivo imaging ...[more]
  150. EMT Company 139
    Biomimetic coronary stent coating that prevents restenosis/reduces the need for extended courses of dual antiplatelet th ...[more]
  151. EMT Company 195
    Non-invasive screening of Peripheral Arterial Disease (PAD), combining postural/infrared blood volume testing ...[more]
  152. EMT Company 670
    Less invasive approach for mitral valve repair, on a beating heart ...[more]
  153. EMT Company 676
    Synthetic graft/stent technology that reduces neo-intimal hyperplasia (NIH) and occurrence/rate of restenosis ...[more]
  154. EMT Company 645
    Recombinant adeno-associated viral (AAV)-based gene therapy as a treatment for congestive heart failure (CHF) ...[more]
  155. EMT Company 478
    Minimally-invasive percutaneous aortic valve replacement systems ...[more]
  156. EMT Company 174
    Dedicated angioplasty and stent systems for the treatment of arterial bifurcations ...[more]
  157. EMT Company 638
    Noninvasive tests for the risk assessment of cardiovascular disease and the detection of early-stage lung/breast/colorec ...[more]
  158. EMT Company 640
    Bioresorbable polymer surgical implants designed to prevent/reduce the formation of post-operative adhesions ...[more]
  159. EMT Company 660
    Non-invasive gene expression-based tests for the monitoring of transplant rejection/autoimmune diseases ...[more]
  160. EMT Company 610
    Biochips to identify gene expression patterns ...[more]
  161. EMT Company 611
    Technology enabling detection and monitoring wirelessly, remotely, and with no contact to the subjects; also through clo ...[more]
  162. EMT Company 615
    Next-generation personal diagnostics for hematological malignancies/autoimmune disorders ...[more]
  163. EMT Company 620
    Next-generation transluminally placed endovascular grafts for the treatment of aneurysmal disease in the AAA/TAA ...[more]
  164. EMT Company 549
    Mesh wrap for permanent implantation around the heart to prevent/reverse the progression of heart failure ...[more]
  165. EMT Company 558
    Advanced trilobal pericardial valve technologies ...[more]
  166. EMT Company 580
    3-D tracking devices for use in surgical navigation and MIS ...[more]
  167. EMT Company 108
    Percutaneous access management system to provide early ambulation/eliminate major complications, leaving nothing behind ...[more]
  168. EMT Company 582
    Device for the treatment of sudden cardiac arrest for both in- and out-of-hospital markets ...[more]
  169. EMT Company 568
    Cerebral protection system to prevent embolic strokes ...[more]
  170. EMT Company 585
    Light-activated drug therapy to transform cancer into a treatable chronic disease ...[more]
  171. EMT Company 555
    De-cellularized biological scaffolds meant to function like native tissue ...[more]
  172. EMT Company 556
    Wireless ECG monitoring ...[more]
  173. EMT Company 444
    Bioprosthetic heart valve with a percutaneously-exchangeable leaflet set that provides lifetime service without anti-coa ...[more]
  174. EMT Company 518
    A platform for minimally-invasive cardiac surgery (MICS) via single-port, subxiphoid access, and an endoscope that reach ...[more]
  175. EMT Company 519
    Plaque vulnerability biomarkers to detect patients at risk for the development of stroke, myocardial infarction or claud ...[more]
  176. EMT Company 520
    Minimally invasive surgical procedure intended to reduce the incidence of stroke/thromboembolism associated with atrial ...[more]
  177. EMT Company 533
    Device to improve drainage following heart, lung, and trauma surgery, as well as other procedures where drainage is crit ...[more]
  178. EMT Company 521
    Miniature intravascular flow augmentation device for every organ that needs temporary change of flow ...[more]
  179. EMT Company 523
    Non-epigenetic cell reprogramming technology that enables the generation of patient-identical replacement tissue/organs ...[more]
  180. EMT Company 544
    System to process/concentrate cellular components from autologous bone marrow, including adult stem cells, at the point- ...[more]
  181. EMT Company 545
    Membrane optimization, coatings technologies, and development of polymers for biomedical applications ...[more]
  182. EMT Company 537
    Computer-controlled pressure garments for the effective treatment of lymphedema/chronic wound healing ...[more]
  183. EMT Company 538
    Neo-organs/tissues derived from the patient's own (autologous) cells ...[more]
  184. EMT Company 539
    Stent technology for the treatment of atherosclerotic disease at/near bifurcations ...[more]
  185. EMT Company 153
    Percutaneous mitral valve repair simulating precision of surgical annuloplasty ...[more]
  186. EMT Company 483
    Treatment for ischemia via stem cell-based therapies ...[more]
  187. EMT Company 487
    Bifurcated stenting ...[more]
  188. EMT Company 488
    Non-intrusive patient-monitoring systems that facilitate timely intervention for cardiac/respiratory deterioration ...[more]
  189. EMT Company 490
    Human-based tissue scaffolds ...[more]
  190. EMT Company 493
    Real-time imaging/image guidance for the operating room ...[more]
  191. EMT Company 503
    Hydrogel matrix with applications across multiple specialties ...[more]
  192. EMT Company 458
    A unique solution similar to ring annuloplasty/edge-to-edge repair, all in one modality, for mitral valve repair ...[more]
  193. EMT Company 378
    Mobile phone-based data collection for chronic disease management ...[more]
  194. EMT Company 470
    Inferior vena cava filters ...[more]
  195. EMT Company 472
    Ventricular elastic support therapy for heart failure ...[more]
  196. EMT Company 408
    Products to diagnose the risk for heart attacks by means of assessing endothelial function ...[more]
  197. EMT Company 427
    Third-generation biodegradable annuloplasty rings ...[more]
  198. EMT Company 418
    Miniature blood pump, designed to be placed superficially like a pacemaker, for the long-term treatment of chronic heart ...[more]
  199. EMT Company 428
    Low-mass PFO closure system capable of repairing the defect from within the tunnel ...[more]
  200. EMT Company 350
    Percutaneous mitral valve replacement system for treatment of mitral regurgitation ...[more]
  201. EMT Company 432
    Wireless electronic skin patch sensors for the real-time measurement/monitoring/diagnosis/clinical management of cardiac ...[more]
  202. EMT Company 373
    Catheter-based devices which rapidly provide quantitative data to the physician about vessel and stent size, suitable fo ...[more]
  203. EMT Company 412
    RNA-based therapeutics ...[more]
  204. EMT Company 414
    A portable breath collection apparatus (BCA) which can collect breath samples virtually anywhere, for highly sensitive l ...[more]
  205. EMT Company 393
    Low cost, easy-to-use, credit-card-sized devices which will allow on-the-spot quantitative diagnosis ...[more]
  206. EMT Company 435
    System that performs a non-invasive, 30-second test to identify the risk of heart disease ...[more]
  207. EMT Company 443
    Advanced suturing technology for minimally invasive/NOTES/bariatric/cardiac/other surgical specialties ...[more]
  208. EMT Company 391
    Devices for treating cardiovascular disease ...[more]
  209. EMT Company 360
    Non-invasive robotic radiosurgery system for cardiac ablation ...[more]
  210. EMT Company 271
    Repositionable/removable percutaneous heart valve, precision controlled delivery device, and calcified valve encapsulati ...[more]
  211. EMT Company 362
    Device based therapy targeting ischemic brain stroke and chronic heart failure ...[more]
  212. EMT Company 363
    Site-specific catheter-guided system to deliver drugs and biologics directly to the adventitia ...[more]
  213. EMT Company 67
    Implantable blood pump with magnetic levitation technology for patients suffering from heart failure ...[more]
  214. EMT Company 175
    Specialty and standard electrophysiology catheters that have superior performance, advantageous features, and are afford ...[more]
  215. EMT Company 309
    Tools for enabling adult stem cell based regenerative medicine ...[more]
  216. EMT Company 370
    Cell-based epicardial patch designed to promote blood vessel growth in ischemic cardiac tissue ...[more]
  217. EMT Company 342
    An absolutely non-invasive, radiation- and side-effect free electro physiological high speed cardiac diagnostic system t ...[more]
  218. EMT Company 343
    Developing a fully implantable extra-aortic counterpulsation device designed to provide long-term, cost-effective treatm ...[more]
  219. EMT Company 339
    Non-surgical serum based cure, proven effective for PAD, Diabetic and Cardiovascular disorders ...[more]
  220. EMT Company 208
    Bifurcated coronary stent ...[more]
  221. EMT Company 137
    Electrode sensor array, with integrated lead wires, simple, accurate and repeatable ECGs ...[more]
  222. EMT Company 317
    Wireless patient vital signs monitoring ...[more]
  223. EMT Company 283
    Percutaneously delivered implantable system to treat mitral valve regurgitation and improve congestive heart failure ...[more]
  224. EMT Company 190
    1- Interventional single-use cardiac support device and drug delivery platform, 2- Implants for use in/with magnetic res ...[more]
  225. EMT Company 286
    1-Cardiovascular-directed growth factor therapeutics; 2-Endovascular catheter-based system to rapidly and controllably c ...[more]
  226. EMT Company 287
    Non-invasive cardiac output monitoring to assess stroke volume, contractility, cardiac output, cardiac index, and thorac ...[more]
  227. EMT Company 292
    An internal adhesive biotechnology designed for strength, biocompatibility, and ease-of-use with applications in cardiov ...[more]
  228. EMT Company 269
    Heart pump that achieves superior flow and pressure performance, mimicking the physiological performance of the human he ...[more]
  229. EMT Company 21
    Interventional catheter system for the mechanical recanalization of arterial chronic total occlusions quickly and reliab ...[more]
  230. EMT Company 148
    Perfusion monitoring for preventing septic shock, the greatest hospital mortality ...[more]
  231. EMT Company 221
    Fiber-optic, catheter-based, near-infrared (NIR) spectroscopy system to identify lipid rich plaques in the coronary arte ...[more]
  232. EMT Company 298
    Digital Pulse Analyzer - provides early detection of arterial wall stiffness and biological age of arteries ...[more]
  233. EMT Company 299
    Endothelial management - less trauma combined with new agents for improved healing in vascular interventions ...[more]
  234. EMT Company 303
    ECG software for assessing acute ischemia and cardiac safety surrogates in clinical trials ...[more]
  235. EMT Company 236
    Medical devices, utilizing robust tyrosine-based resorbable polymer systems/pharmaceuticals in surgical barriers/cardiac ...[more]
  236. EMT Company 316
    Disease management system for early detection of heart failure using a noninvasive cardiovascular-sleep prognostic marke ...[more]
  237. EMT Company 270
    Next-generation estrogen-based drug-eluting coronary stent and an orthopedics/sports injury pain management device ...[more]
  238. EMT Company 172
    System to ablate cardiac tissue as a means to potentially treat atrial fibrillation ...[more]
  239. EMT Company 151
    Advanced ECG-heart sound analysis to enable superior diagnosis/monitoring of CHF/ACS patients ...[more]
  240. EMT Company 160
    A platelet reactivity test to measure the effect of anti-platelet drugs, particularly aspirin and Plavix ...[more]
  241. EMT Company 931
    Visually guided catheter ablation for atrial fibrillation ...[more]
  242. EMT Company 186
    Dynamic optimization of pacing intervals according to hemodynamic sensors for CRT devices ...[more]
  243. EMT Company 205
    A suite of tools for automated CT Angiography (CTA) diagnostics for Coronary Artery Disease ...[more]
  244. EMT Company 107
    Totally implantable LVAD that does not interface with circulating blood ...[more]
  245. EMT Company 169
    System analyzes a patient's susceptibility to cardiac arrest and consequent need for implantable defibrillator ...[more]
  246. EMT Company 170
    Interventional MRI technology for cardiovascular imaging including detection/treatment of vulnerable plaque ...[more]
  247. EMT Company 144
    Catheter-based devices to reconstruct the ventricle and downsize the heart volume ...[more]
  248. EMT Company 141
    Minimally invasive device-based technologies targeting the treatment of hemodynamic instability and perfusion ...[more]
  249. EMT Company 53
    Cath lab solution providing rapid onset of circulatory support in patients with acute heart failure ...[more]
  250. EMT Company 146
    Stentless aortic valve prosthesis to be delivered via catheter ...[more]
  251. EMT Company 154
    Surgical and percutaneous cardiac valve repair ...[more]
  252. EMT Company 156
    A wearable continuous ultrafiltration device that removes fluid overload in patients with Congestive Heart Failure ...[more]
  253. EMT Company 71
    Catheter-based sealing of heart defects associated with stroke, migraine headaches, and other brain attacks ...[more]
  254. EMT Company 72
    Complete pre-configured system for implementing minimized cardiopulmonary bypass ...[more]
  255. EMT Company 136
    In vivo plasmapheresis and ultrafiltration to remove excess fluid from CHF patients in clinical trials ...[more]
  256. EMT Company 163
    Minimally invasive telemetric and continuous measurement of left atrial blood pressure at heart failure ...[more]
  257. EMT Company 104
    A device for the left atrial appendage for stroke prevention in patients with atrial fibrillation ...[more]
  258. EMT Company 113
    Bioabsorbable drug eluting stents and stent coatings for treatment of vulnerable plaque and coronary stenosis ...[more]
  259. EMT Company 114
    Implantable Left Ventricular Assist Device (LVAD) for heart failure ...[more]
  260. EMT Company 116
    Capture and analysis of heart sounds leading to rapid and accurate diagnosis of cardiac pathologies ...[more]
  261. EMT Company 124
    Device for the treatment of mitral regurgitation and heart failure without requiring open heart surgery ...[more]
  262. EMT Company 111
    Microsyringe delivery of cells, genes, and drugs to the vasculature/deep tissues of the body ...[more]
  263. EMT Company 135
    Noninvasive therapeutic ultrasound to enhance perfusion for treatment of acute myocardial infarction ...[more]
  264. EMT Company 44
    Portable, compact, easy-to-use automated external defibrillators with full energy delivery and complete resuscitation so ...[more]
  265. EMT Company 47
    Non-irritating dry electrodes now enabling long-term cardiac monitoring ...[more]
  266. EMT Company 54
    Direct, real-time vision through flowing blood to guide therapy inside the heart and vessels ...[more]
  267. EMT Company 57
    Technology that non-invasively measures/monitors mechanical heart function and disease utilizing a disposable brachial c ...[more]
  268. EMT Company 61
    Non-blood contacting, active implantable direct cardiac compression device for the treatment of CHF ...[more]
  269. EMT Company 62
    Continuous blood gas monitoring and cardiac output measurement for the intensive care unit ...[more]
  270. EMT Company 63
    Point-of-care platform technology for assessing risk of cardiovascular disease and renal dysfunction ...[more]
  271. EMT Company 3
    Intravascular temperature management systems and catheters for cardiac and neuro intensive care patients ...[more]
  272. EMT Company 7
    A five-carbon carbohydrate that increases cellular energy, improving cardiovascular health and tissue function ...[more]
  273. EMT Company 19
    Monitor for autonomic nervous system displaying sympathovagal balance in real-time for diabetes/ anesthesia/cardiology a ...[more]
  274. EMT Company 28
    A wireless, early detection and auto-alerting heart monitor system for outpatient and homecare markets ...[more]
  275. EMT Company 30
    Helical stent providing enhanced abilities and flexibilities in drug delivery, scaffolding, and embolic protection ...[more]
  276. EMT Company 33
    System that prevents embolic events by removing plaque and thrombus found in diseased arteries ...[more]
  277. EMT Company 36
    Catheters designed to diagnose, terminate, and treat cardiac arrhythmia during EP and ablation procedures ...[more]